Modafinil and memory: effects of modafinil on Morris water maze learning and Pavlovian fear conditioning.


     Related Videos
World Memory Champion (Wang Feng) Memory Lecture Part-5 - YouTube
World Memory Champion (Wang Feng) Memory Lecture Part-6 - YouTube
World Memory Champion (Wang Feng) Memory Lecture Part-4 - YouTube
Lecture -13 Virtual Memory and Memory Management Unit - YouTube
Lecture - 31 Memory Hierarchy Virtual Memory

     Related Hubpages

    •  Doc. Url:    Embed Code: 

    • PubMed  status
      (0) (0 Votes)
      Views: ()   Date: (2009-5-19)   Pages: ()
    • Author:  Stephan G Anagnostaras  

    • Abstract:  Modafinil has been shown to promote wakefulness and some studies suggest the drug can improve cognitive function. Because of many similarities, the mechanism of action may be comparable to classical psychostimulants, although the exact mechanisms of modafinil's actions in wakefulness and cognitive enhancement are unknown. The current study aims to further examine the effects of modafinil as a cognitive enhancer on hippocampus-dependen t memory in mice. A high dose of modafinil (75 mg/kg ip) given before training improved acquisition on a Morris water maze. When given only before testing, modafinil did not affect water maze performance. We also examined modafinil (0.075 to 75 mg/kg) on Pavlovian fear conditioning. A low dose of pretraining modafinil (0.75 mg/kg) enhanced memory of contextual fear conditioning (tested off-drug 1 week later) whereas a high dose (75 mg/kg) disrupted memory. Pretraining modafinil did not affect cued conditioning at any dose tested, and immediate posttraining modafinil had no effect on either cued or contextual fear. These results suggest that modafinil's effects of memory are more selective than amphetamine or cocaine and specific to hippocampus-dependen t memory.

         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

                 Answers

                 News
            • Grant aimed at improving schizophrenia treatment
              (SACRAMENTO, Calif.) - Michael Minzenberg, a UC Davis psychiatry researcher, has been awarded a prestigious three-year, $200,000 seed grant from the Dana Foundation to study the brains of patients being treated for schizophrenia
            • Grant will fund study of cognition and schizophrenia
              SACRAMENTO — Michael Minzenberg, a UC Davis psychiatry researcher, has been awarded a prestigious three-year, $200,000 seed grant from the Dana Foundation to study the brains of patients being treated for schizophrenia to determine how additional treatment to improve cognition interacts with antipsychotic medication.
            • Bullets to beat the enemy within
              ARMY leaders in various countries have trialled compounds that can keep soldiers awake and alert — or send them to sleep
            • Regeneron reports total revenues of $123.0M for fourth quarter 2011
              Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.
            • Is it true that someone with Sleep Apnea is more likely to have a motor vehicle accident than ...
              Dear Dr. Rosenberg, Is it true that someone with Sleep Apnea is more likely to have a motor vehicle accident than others? My son has Sleep Apnea and refuses to get treated. He and his wife just had their first child, so I am concerned. Should I be? Yes, you should. The incidence of MVA (Motor Vehicle Accidents) in men with Sleep Apnea is three times the risk of others. Interestingly, it is less ...
            • How dementia drugs could be used by the military
              Army leaders in various countries have trialled compounds that can keep soldiers awake and alert – or send them to sleep Drugs that reduce anxiety, tiredness and memory loss – all associated with the treatment of dementia – could be used "off-label" as cognitive enhancers by military personnel, according to a Royal Society report . While caffeine and nicotine are used routinely to reduce fatigue ...
            • Neuroprotection - Drugs, Markets and Companies
              NEW YORK, Feb. 1, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Neuroprotection - Drugs, Markets and Companies http://www.reportlinker.com/p0203546/Neuroprotection---Drugs-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ...
            • We must be science's masters, not at its mercy | John Harris
              Recent advances in neuroscience, such as memory manipulation, create compelling ethical dilemmas This week it was reported that soldiers could potentially, in the near future, have their minds plugged directly into weapons systems , and have their learning boosted by neural stimulation. The Royal Society's Brain Waves project on new directions in neuroscience gives us much to reflect on and ...
            • Immunome Launches $1.5 Million Offering - cbl
              By Bill Murphy WYNNEWOOD, Pa. -- Immunome Inc. has raised $145,000, or nearly a tenth of a $1.50 mil...

                 Related on Wikipedia




























               

              Powered free by PHPmotion